Results 31 to 40 of about 5,616 (255)

Aportes al debate de legalización del uso medicinal de la marihuana en Colombia

Revista Facultad Nacional de Salud Pública, 2017
Es intenso el debate sobre legalización de la marihuana para usos terapéuticos, buscando minimizar la criminalización del usuario. Paradójicamente a pesar de la evidencia de efectos nocivos de la marihuana su consumo aumenta, hay altas prevalencias ...
Guillermo Castaño Pérez, Elvia Velásquez, Alvaro Olaya Pelaéz   +2 more
doaj   +1 more source

Effects of Cannabidiol‐Rich Cannabis Oil on Facial Expression Recognition and Theory of Mind in Children With Autism Spectrum Disorder: A Randomized Clinical Trial

Autism Research, EarlyView.
ABSTRACT To evaluate, in a post hoc subanalysis, the effects of cannabidiol (CBD)‐rich cannabis oil on facial expression recognition and theory of mind in children with autism spectrum disorder (ASD). This post hoc subanalysis included children from a double‐blind, randomized, placebo‐controlled trial who completed social cognition assessments at ...
Wandersonia Moreira Brito Medeiros, Estácio Amaro da Silva Junior, Katy Lísias Gondim Dias de Albuquerque, Marine Diniz da Rosa, Amanda Gleiciane de Lima Oliveira, Maycon Jônatas da Silva, João Vitor Andrade Fernandes, Emily Caroline Costa Vieira, João Paulo Mendes dos Santos, Thais Cavalcanti Borges, Ana Hermínia Andrade e Silva, Carlos Espínola Neto Segundo, Nelson Torro‐Alves   +12 more
wiley   +1 more source

Progresión y escalonamiento en el consumo de drogas: evidencia para Argentina

Estudios Económicos, 2019
El objetivo de este trabajo es estudiar, para Argentina, la progresión en el consumo de drogas que se inicia con el consumo de drogas legales y avanza hacia el consumo de marihuana, cocaína y otras drogas ilícitas.
María Inés Lara, Monserrat Serio, María Noelia Garbero   +2 more
doaj   +2 more sources

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

British Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, Volker Auwärter   +7 more
wiley   +1 more source

Efectos adversos de la marihuana en la edad pediátrica: su conocimiento ¿podría limitar la legalización de la droga en México?

Boletín Médico del Hospital Infantil de México, 2014
En el presente trabajo se realiza una reflexión acerca de si el exponer, conocer y precisar los efectos de la marihuana en la adolescente embarazada y en el producto de la gestación serían un factor determinante para poder considerar más juiciosamente la
Arturo Loredo Abdalá, Abigail Casas Muñoz, Daniela Alejandra Monroy Llaguno   +2 more
doaj   +1 more source

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Evaluation of a pantoprazole and 4‐desmethylpantoprazole‐sulfate metabolic ratio as a novel CYP2C19 phenotyping method

British Journal of Clinical Pharmacology, EarlyView.
Aims CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.
Julian Peter Müller, Vladimir N. Belov, Sabrina Yamoune, Bob Miller, Mohammed Hasoumi, Jolanta Tupiec, Thea Laurentius, L. Cornelius Bollheimer, Julia C. Stingl, Katja S. Just   +9 more
wiley   +1 more source

Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to evaluate the efficacy and safety of cannabinoids for the treatment of MS‐related spasticity. Methods Systematic searches were conducted in PubMed, EMBASE, and LILACS on 2 December 2025. Randomized controlled trials evaluating natural or synthetic cannabinoids for MS‐related spasticity were included.
Letícia Hamm‐Buiar, Daniela Gorski, Marcela Harumi Kagueiama, Astrid Wiens   +3 more
wiley   +1 more source

Argumentos para el debate sobre la legalización de la marihuana en México

Entreciencias: Diálogos en la Sociedad del Conocimiento, 2013
La legalización de la marihuana en México ha generado intenso debate. La complejidad del fenómeno merece que se expongan detalladamente los puntos a favor y en contra de la legalización de una tercera sustancia adictiva aparte del ...
Sofía Hernández González, Julio Sotelo Morales   +1 more
doaj  

Cannabis: challenges between legislation and cognitive competence

International Journal of Psychological Research, 2015
Marihuana (Cannabis) is the most consumed illicit drug worldwide. By 2013, 180,6 million people, that is 3.9 % of the world population consumed the substance, within a wide range of age (15 to 64 years old).
Jorge Mauricio Cuartas Arias
doaj   +1 more source